Incyte INCY announced new 24-week interim data from the STOP-HS program on pipeline candidate, povorcitinib (INCB54707), in adult patients with moderate to severe hidradenitis suppurativa (HS). The ...
If spiders are your particular trigger, then look away now, but be aware that experts in the field of our eight-legged friends are warning everyone to keep windows firmly closed for the coming month ...
Incyte halts MRGPRX2 Phase 2 enrollment in CSU after preclinical toxicology findings, sharing data with the FDA. Analyst notes 2025 pipeline updates may shift investor focus, including povorcitinib ...
Incyte Corporation (NASDAQ:INCY) ranks among the most undervalued NASDAQ stocks to buy now. Citizens JMP reaffirmed its Market Perform rating on Incyte Corporation (NASDAQ:INCY) on September 18 after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback